Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.810
+0.390 (8.82%)
Aug 21, 2026, 12:22 PM EDT - Market open
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $178.85 million as of August 21, 2026. Its market cap has increased by 96.67% in one year.
Market Cap
178.85M
Enterprise Value
468.85M
1-Year Change
96.67%
Ranking
Category
Stock Price
$4.81
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $178.85M, an increase of 286.16%. That is a compound annual growth rate of 20.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 178.85M | -21.78% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 181.97M |
| MediWound | 176.10M |
| Nkarta | 172.62M |
| OnKure Therapeutics | 170.49M |
| Caribou Biosciences | 167.24M |
| Kazia Therapeutics | 164.32M |
| Codexis | 164.26M |
| Humacyte | 161.60M |